Max Healthcare Institute Limited has informed the Exchange regarding Change in Auditors of the company.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare's board approved audited consolidated FY25 results showing revenue from operations of ₹7,02,846 lakhs (up ~30% from ₹5,40,602 lakhs in FY24) and profit after tax of ₹1,07,588 lakhs (vs ₹1,05,764 lakhs). Q4 FY25 revenue was ₹1,90,974 lakhs with PAT of ₹31,900 lakhs. The board recommended a final dividend of ₹1.5 per share (15% of face value). Deloitte Haskins & Sells completed its 5-year statutory auditor tenure and will be replaced by S.R. Batliboi & Co. LLP for a fresh 5-year term (FY26–FY30). The company also announced expansion of ~100 beds at Max Super Speciality Hospital, Nagpur and ~120 beds at Vaishali (Ghaziabad), and divested its stake in a small hydro-power unit for ~₹1.28 crore. Deloitte issued an unmodified audit opinion.
Routine auditor rotation after completion of Deloitte's 5-year term; no governance red flags. Strong revenue growth (~30%) and steady PAT growth signal healthy operations, while the recommended dividend and bed-expansion plans are positive for shareholders. No negative signals for the stock.